PLCXD3 and metabolic dysfunction-associated steatotic liver disease: Based on our bioinformatics analyses, we found that PLCXD3 and PKD2 might provide a novel perspective to understand the disease progression of advanced NAFLD and AS, and these results might serve as a theoretical basis for further experimental studies in this direction.